Why Takeda (TAK) Is One of the Most Profitable Pharmaceutical Stocks Right Now?

Yahoo FinanceNov 30 16:29 ET

Hutchmed to Receive Milestone Payment for Takeda's Fruzaqla Launch in Japan

MT NewswiresNov 22 04:01 ET

ADR Japanese stock rankings - overall buying dominance including Orient Land, Chicago at 38,230 yen, 190 yen higher than Osaka.

Japanese stocks of ADR (american depositary receipt) compared to the Tokyo Stock Exchange (calculated at 154.51 yen per dollar), such as Orion Land <4661>, Mitsubishi Corporation <8058>, komatsu <6301>, Disco <6146>, Tokyo Electron <8035>, SoftBank Group <9984>, Mizuho Financial Group <8411>, have risen, with buying pressure prevailing overall. The settlement price of the Chicago Nikkei 225 futures is 38,230 yen, which is 190 yen higher than during the Osaka day session. The US stock market has risen, with the dow inc gaining 461.88 dollars.

Fisco JapanNov 21 18:11 ET

Regarding the launch of Fruquakra (Fulkinchynib) in japan for unresectable advanced or recurrent colorectal cancer.

Regarding the release of Furuzakura (Furukintinib) in japan for unresectable advanced or recurrent colorectal cancer that cannot be cured, on November 22, 2024, our company today announced the release of the orally administered tyrosine kinase inhibitor "Furuzakura Capsule 1mg/5mg" (generic name: Furukintinib), which has selectivity for vascular endothelial growth factor receptors (VEGFR) 1/2/3, for "unresectable advanced or recurrent colon and rectal cancer that worsened after cancer chemotherapy."

Takeda PharmaceuticalNov 21 10:00 ET

Regarding the release of the oral proteasome inhibitor "Ninlaro capsules 0.5 mg" in japan.

Regarding the launch of the oral proteasome inhibitor "Ninlaro Capsule 0.5 mg" in japan on November 22, 2024, the company announces that it has launched the oral proteasome inhibitor "Ninlaro Capsule 0.5 mg" (generic name: ixazomib citrate, hereafter referred to as "Ninlaro 0.5 mg") today. This is an additional formulation to the existing "Ninlaro Capsules 2.3 mg/3 mg/4 mg," which will be used in maintenance therapy for multiple myeloma.

Takeda PharmaceuticalNov 21 10:00 ET

The Nikkei average starts 0.53 yen higher, with companies like Furukawa Electric and MS&AD rising.

[Nikkei Average Stock Price・TOPIX (Table)] Nikkei Average; 38352.87; +0.53 TOPIX; 2700.14; +1.85 [Opening Overview] On the 21st, the Nikkei Average started trading up 0.53 yen at 38352.87 yen. The previous day, on the 20th, the U.S. stock market was mixed. The dow inc rose by 139.53 dollars to 43408.47 dollars, while the nasdaq closed down 21.33 points at 18966.14. Ukraine has provided British-made long-range missiles to Russia.

Fisco JapanNov 20 19:40 ET